Item 2.02  Results of Operations and Financial Condition.
On January 6, 2022, Biohaven Pharmaceutical Holding Company Ltd. (the
"Company"), issued a press release announcing preliminary fourth quarter 2021
and full year 2021 net product revenue results for NURTEC ODT. The information
in the press release reflects the Company's estimate with respect to net product
revenue for NURTEC ODT based on currently available information which is
preliminary and unaudited, is not a comprehensive statement of the Company's
financial results for the fourth quarter of 2021 or full year 2021 and is
subject to completion of the Company's financial closing procedures for the
quarter. The Company's final results for the net product revenue for NURTEC ODT
that will be issued upon completion of its closing procedures may vary from the
preliminary estimate. A copy of the press release is furnished herewith as
Exhibit 99.1 to this Current Report and is incorporated herein by reference.
In accordance with General Instruction B.2. of Form 8-K, the information in this
Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liability of that section, nor shall it be
deemed incorporated by reference in any of the Registrant's filings under the
Securities Act of 1933, as amended, or the Exchange Act, whether made before or
after the date hereof, regardless of any incorporation language in such a
filing, except as expressly set forth by specific reference in such a filing.
Special Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act. These statements relate to future events and involve known and unknown
risks, uncertainties and other factors which may cause the Company's actual
results, performance or achievements to be materially different from any future
results, performances or achievements expressed or implied by the
forward-looking statements. In some cases, you can identify forward-looking
statements by terms such as "may", "will", "should", "could", "would",
"expects", "plans", "anticipates", "believes", "estimates", "projects",
"predicts", "potential" and similar expressions intended to identify forward
looking statements. These statements reflect the Company's current views with
respect to future events and are based on assumptions and subject to risks and
uncertainties. Given these uncertainties, you should not place undue reliance on
these forward-looking statements. Also, these forward-looking statements
represent the Company's estimates and assumptions only as of the date of this
Current Report on Form 8-K.
Item 9.01  Financial Statements and Exhibits.

(d) Exhibits

      Exhibit Number                                      Exhibit Description
           99.1                    Press Release, dated January 6, 2022 issued by Biohaven
                                 Pharmaceutical Holding Company Ltd.
           104                   The cover page of this Current Report on Form 8-K formatted as Inline
                                 XBRL.


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses